Stocks · Health care · Pharmaceutical Preparations

OMEROS CORP

OMER Clue Score25
United States Fiscal year ends December CIK 0001285819 Results filed 12 Aug 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
David J. Borges
12 Jan 2026
VP, Finance & CAO
Sell
30,000
$12.72
$381.60K
Michael A Jacobsen
19 Jan 2021
VP Finance and CAO
Sell
9,500
$19.95
$189.53K
Thomas J. Cable
14 Oct 2019
Director
Sell
5,000
$15.12
$75.59K
Thomas J. Cable
12 Apr 2017
Director
Sell
3,000
$16.49
$49.47K
Thomas J. Cable
14 Dec 2016
Director
Sell
3,000
$10.21
$30.64K

What was left out

Form 4 filings counted 161
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 48
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,710,778
Sales filed before the plan box existed 4
History held since 13 Oct 2009